Green Cross says adjuvant promising in new flu vaccine

Green Cross Corporation, a local drug maker responsible for the domestic production of the flu vaccine, said that its new vaccine with an adjuvant demonstrated excellent antibody-producing effects against the H1N1 flu virus in animal experiments.

Led by Professor Choi Young-gi of Chungbuk University and colleagues, the animal tests showed that the vaccine with Novartis’s adjuvant MF59 produc...